RGLI002-2 Brain cancer cell line
Novel patient-derived cell lines (PDCs) have been constructed under the Fukushima Translational Research Project. Our comparative histological and comprehensive gene expression analyses have shown that the characteristics of PDCs were…
Contributors
| Inventor | Institute |
|---|---|
| Medical-Industrial Translational Research Center | Fukushima Medical University |
| SKU: | 160986 |
|---|---|
| Product description: | Novel patient-derived cell lines (PDCs) have been constructed under the Fukushima Translational Research Project. Our comparative histological and comprehensive gene expression analyses have shown that the characteristics of PDCs were similar to their source tumors, even after long-term growth in culture conditions |
| Alternate name: | RGLI002-2, RGLI2-2, RGLI2, RGLI002 |
| Gender: | Female |
| Cellosaurus ID: | CVCL_E3NN |
| Cat. #: | 160986 |
|---|---|
| Unit size: | 1 ml |
| Cancer types: | Brain cancer |
| Research Fields: | Cancer |
| Organism: | Human |
| Tissue: | Brain |
| Gender: | Female |
| Growth properties: | Adherent |
| Cancer Types In Detail: | Brain neoplasms;Gliosarcoma |
| Format: | Frozen |
|---|---|
| Storage conditions: | Liquid Nitrogen |
| Shipping conditions: | Dry ice |
| Growth medium: | Neurobasal? Medium (Thermo Fisher Scientific: 21103049) with 1% N2 |
| Temperature: | 37° C |
| Atmosphere: | 5% CO2 |
| Storage medium: | CELLBANKER 2 |
| Mycoplasma free: | Yes |
| Biosafety level: | 1 |
Images
View Gallery
Product Images
16098620-2076520×20500-1.png
